Publication | Closed Access

Efficacy and safety of celgosivir in patients with dengue fever (CELADEN): a phase 1b, randomised, double-blind, placebo-controlled, proof-of-concept trial

Phase 1BProof-of-concept TrialClinical TrialsAntiviral TherapyDengue FeverPharmacotherapyMedicineVector Borne Disease